Medicare Enrolled

Dr. Attica Chang, M.D.

Optician · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1356 NW BOCA RATON BLVD, Boca Raton, FL 33432
5613959500
In practice since 2006 (20 years)
NPI: 1225099781 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chang

Dr. Attica Chang is an optician in Boca Raton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Chang performed 12,790 Medicare services across 5,592 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chang received a total of $6,591 from 34 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 6% volume in FL$ $6,591 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,790
Medicare services
Top 6% in FL for optician
5,592
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~640 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-143,853$5$10
Tissue pathology examination, moderate complexity2,088$56$128
Office visit, established patient (20-29 min)1,338$54$80
Skin biopsy, tangential1,128$67$130
Destruction of precancerous skin growth, 1951$35$106
Biopsy of related skin growth, each additional growth822$40$70
Destruction of skin growths (warts/lesions), 1-14446$86$143
Destruction of precancer skin growth, 15 or more growths372$137$233
New patient office visit (30-44 min)182$76$140
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks154$343$533
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks143$422$900
Steroid injection (triamcinolone)132$1$2
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm131$124$216
Tissue staining for diagnosis, additional94$22$28
Destruction of skin growth, 15 or more growths76$100$172
Biopsy of ear74$48$138
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm73$136$235
Injection into skin growth, 1-7 growths72$34$73
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm65$150$256
Special stained specimen slides to identify organisms including interpretation and report61$89$128
Tissue staining for diagnosis, initial51$28$55
Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less40$639$1,038
Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm33$114$193
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)32$307$506
Complicated or multiple drainage of skin abscess30$174$282
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm29$137$250
Application of light with debridement to destroy precancer skin growth28$205$332
Punch biopsy, first skin growth26$95$164
Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm26$723$1,185
Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less24$574$943
Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks22$382$819
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm20$163$278
Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks20$328$495
Repair of wound of trunk by transferring skin, 10.0 sq cm or less19$533$842
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm18$143$240
Repair of wound of trunk by transferring skin, 10.1-30.0 sq cm17$696$1,091
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm17$162$275
Drug injection, under skin or into muscle17$11$27
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and16$43$71
Simple or single drainage of skin abscess14$96$161
Partial thickness self skin graft to face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less12$724$1,294
Biopsy of lip12$90$174
Biopsy of eyelid12$137$284
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,591
Total received (2018-2024)
Avg $942/year across 7 years
Top 19% in FL for optician
34
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,335 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,409
2023
$1,016
2022
$907
2021
$745
2020
$518
2019
$1,112
2018
$884

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merz North America, Inc.
$812
Janssen Biotech, Inc.
$564
Galderma Laboratories, L.P.
$562
Regeneron Healthcare Solutions, Inc.
$559
GENZYME CORPORATION
$458
Sun Pharmaceutical Industries Inc.
$435
AbbVie Inc.
$372
SUN PHARMACEUTICAL INDUSTRIES INC.
$337
ABBVIE INC.
$314
AbbVie, Inc.
$283
Boehringer Ingelheim Pharmaceuticals, Inc.
$273
Incyte Corporation
$227
Novartis Pharmaceuticals Corporation
$174
Almirall LLC
$168
Lilly USA, LLC
$147
PFIZER INC.
$117
SANOFI-AVENTIS U.S. LLC
$100
LEO Pharma Inc.
$99
Biofrontera Inc.
$88
NOVARTIS PHARMACEUTICALS CORPORATION
$82
Amgen Inc.
$74
DUSA Pharmaceuticals, Inc.
$72
Ortho Dermatologics, a division of Bausch Health US, LLC
$70
UCB, Inc.
$42
Mayne Pharma Inc.
$22
Organogenesis Inc.
$21
ORGANOGENESIS INC.
$19
DERMIRA, INC.
$19
EPI Health, LLC
$16
Sensus Healthcare, Inc.
$15
Taro Pharmaceuticals USA, Inc.
$15
Celgene Corporation
$13
iCAD, Inc
$12
STRATA Skin Sciences, Inc.
$12
Top 3 companies account for 29.4% of total payments
Associated products mentioned in payments ›
0.25% · 20% · ABSORICA (isotretinoin) · ADBRY · AKLIEF · ALTRENO · AMELUZ · AXXENT SURFACE CONTROLLER · Ameluz · BF-RhodoLED · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · EUCRISA · HUMIRA · Humira · ILUMYA · JUBLIA · Klisyri · LEVULAN KERASTICK · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OPZELURA · ORACEA · Odomzo · Otezla · Puraply · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · Veltin · XEOMIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $52 per 100 Medicare services performed
Looking for a optician in Boca Raton?
Compare opticians in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
553
Per 100K population
36.7
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chang is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (low-engagement, top 19%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chang experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Chang performed 3,853 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chang receive payments from pharmaceutical companies?
Yes. Dr. Chang received a total of $6,591 from 34 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chang's costs compare to other opticians in Boca Raton?
Dr. Chang's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →